2XDC

Structure of linear gramicidin D obtained using Type I crystals grown in a lipid cubic phase.

External Resource: Annotation

Protein Modification Annotation

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B, C, D, E A, B, C, D, E, F	DLE	RESID: AA0197 PSI-MOD : D-leucine MOD:00204
A, B, C, D, E A, B, C, D, E, F	DVA	RESID: AA0197 , AA0200 PSI-MOD : D-leucine MOD:00204 , D-valine MOD:00705
A, B, C, D, E A, B, C, D, E, F	ETA	RESID: AA0197 , AA0200
A, B, C, D, E A, B, C, D, E, F	FVA	Parent Component: VAL RESID: AA0197 , AA0200

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.